猪小肠黏膜下层作为板层角膜移植材料的实验研究

小肠黏膜下组织（small intestinal submucosa，SIS）是一种新型的具有生物降解性及胶原组织结构的细胞外基质框架，通常取自猪的空肠，SIS中的胶原蛋白、蛋白多糖及糖蛋白构成的细胞外基质框架无抗原性，植入体内仅引起轻微的排斥反应，可以在体内存活，同时为受体自身细胞的生长提供框架。由于SIS具有无免疫原性、抗微生物活性、促进组织再生等特性，因此得到了广泛研究。     

Mapping B-cell linear epitopes of NS3 protein of bovine viral diarrhea virus

Bovine viral diarrhea virus (BVDV) is a member of the genus Pestivirus within the family Flaviviridae. NS3 is one of the immunodominance regions of the BVDV viral proteins. To identify the potential B-cell linear antigenic epitopes within BVDV NS3 region, serial overlapping truncations covering the whole region were expressed and purified, and screened by multistep of Western-blot. We found (₁VCKKITEHERCHVNI₁₅), (₂₀AFFGVMPRGTTPRAPVR₃₆), (₄₆RRGLETGWAYTHQGGI₆₁), (₂₈₁EGDMATGITYASYGYFC₂₉₇), (₄₂₆YSGEDPANLRVVTSQSPYVVVATNAIESGV₄₅₅) and (₄₈₁FIVTGLKRMAVTVGEQA₄₉₇) can be recognized by the BVDV infected bovine serum. These proteins have been confirmed by indirect enzyme-linked immunosorbent assay (I-ELISA). The results of this study might open new perspectives on the structure and antibody–antigen reaction of the non-structural proteins and may aid in the clinical application as well.     

德菲尔法构建重大动物疫病预警指标体系

[目的 ]构建重大动物疫病暴发流行预警指标体系。[方法 ]以禽流感和口蹄疫为例,采用文献调研法和德菲尔专家咨询法中的专家会议法初拟重大动物疫病预警体系的框架和指标;应用德菲尔专家咨询法评价预警指标的重要性、可操作性;应用组合权重法比较各指标综合影响的大小,并将指标分类。[结果 ]筛选出禽流感和口蹄疫预警预报一级指标6项(易感动物、饲养管理和免疫情况等)以及二级指标14项(免疫效果、环境消毒、温度等),并将指标分为三类(关键指标、重要指标和一般指标)。[结论 ]初步构建了重大动物疫病暴发流行预警指标体系。     

工作犬亚健康的调查分析

本文的撰写基于通过调查确定工作犬亚健康的存在,并分析其产生的症状表现、原因和危害,进而提出适宜有效的防治措施和建议,进一步引起人们对工作犬亚健康的关注,从根本上遏制工作犬亚健康的出现。     

貂,貉,犬病毒性肠炎快速诊断试剂的研究

用金黄葡萄球菌Ａ蛋白（ＳＰＡ）协同凝集方法（ＣｏＡ）对貂、貉、犬病毒性肠炎快速诊断的试剂进行了制备，确定了制备。艺及该制剂的标准操作程序。本制剂特异性强，不与健康动物的组织及其他几种病毒病（犬瘟热、犬传染性肝炎、狂犬病等）发生交叉凝集反应，灵敏度高，通过该制剂ＣｏＡ法与ＨＡ－ＨＩ法比较结果比现行的貂、貉、犬病毒性肠炎ＨＡ－ＨＩ诊断方法检出率高出３０％，同时具有微量、操作简便、易掌握、快速等特点，可在３～５ｍｉｎ获得诊断结果。     

Nitric oxide production by macrophages stimulated with Coccidia sporozoites, lipopolysaccharide, or interferon-gamma, and its dynamic changes in SC and TK strains of chickens infected with Eimeria tenella

Nitric oxide (NO) is an important mediator of innate and acquired immunities. In the studies reported here, we quantified NO produced in vitro by chicken leukocytes and macrophages and in vivo during the course of experimental infection with Eimeria, the causative agent of avian coccidiosis, and identified macrophages as the primary source of inducible NO. Eimeria tenella-infected chickens produced higher levels of NO compared with noninfected controls. In Eimeria-infected animals, SC chickens produced greater amounts of NO compared with infected TK chickens, particularly in the intestinal cecum, the region of the intestine infected by E. tenella. Macrophages that were isolated from normal spleen were a major source of NO induced by interferon (IFN)-gamma, lipopolysaccharide (LPS), and E. tenella sporozoites. Macrophage cell line MQ-NCSU produced high levels of NO in response to Escherichia coli or Salmonella typhi LPS, whereas the HD-11 macrophage cell line was more responsive to IFN-gamma. These findings are discussed in the context of the genetic differences in SC and TK chickens that may contribute to their divergent disease phenotypes.     

检测狂犬病病毒抗原的夹心间接Dot—ELISA的建立和应用研究

本研究建立了检测狂犬病病毒抗原的夹心间接斑点酶联免疫吸附试验(SI-Dot-ELISA).本法检出狂犬病病毒抗原的最低浓度为:0.01IU/mL的标准抗原,1:100000 (相当于20 LD_(50))的狂犬病病毒CVS株和鹿8202株的鼠脑悬液,1:400(相当于7906TCID_(50)/mL)的狂犬病病毒SAG株的细胞培养物.对多种健康动物的组织、健康细胞培养物以及犬瘟热病毒、犬腺病毒等检测均为阴性.用SI—Dot—ELISA、夹心间接ELISA(SI—ELISA)和小鼠脑内接种3种方法,检测了388份材料,检出的阳性份数分别为173、171和179,经统计学处理,3种方法在狂犬病病毒抗原的检测上,可以相互代替.甲醛灭活病毒不影响本方法的检测,而加入氢氧化铝胶后的病毒悬液则不能用本法检测.本法适用于狂犬病的诊断、流行病学调查、疫苗效价的测定和实验研究中病毒抗原的测定.     

猪繁殖与呼吸综合征病毒实验感染SPF猪外周血单核细胞和肺泡巨噬细胞早期凋亡细胞的观察

采用Ａｎｎｅｘｉｎ Ｖ－ＦＩＴＣ／ＰＩ双染色法,用流式细胞仪检测了猪繁殖与呼吸综合征病毒（ＰＲＲＳＶ）实验感染ＳＰＦ猪不同时期外周血单核细胞和肺泡巨噬细胞感染Ａｎｎｅｘｉｎ Ｖ－ＦＩＴＣ＾＋／ＰＩ＾－细胞群（早期凋亡细胞群）。结果显示,ＰＲＲＳＶ感染猪外周血单核细胞和肺泡巨噬细胞Ａｎｎｅｘｉｎ Ｖ－ＦＩＴＣ＾＋／ＰＩ＾－细胞群的表达率均明显高于正常对照猪,感染后２４ｈ表达率达最高值。     

日本对虾的实验室养殖研究

我们曾将发病残存的日本对虾继续养殖作为亲虾,进行夏季高温育苗,所得到的虾苗在实验室里桶养,证明在人工饲养条件下它们是可成活和生长的,本实验还提示,若能解决水质净化问题,日本对虾甚至有可能移至内陆养殖。     

三黄白术片对人工感染鸡传染性法氏囊病的疗效

３组１６日龄小鸡人工感染以鸡传染性法氏囊病（ＩＢＤ）病毒,４８ｈ后出现临床症状,分别内服三黄白术片,剂量分别为０．３７５ｇ,０．２５ｇ和０．１２５ｇ,每日２次,连服５日,随后的１０日内,治疗组分别死亡１３．３％（４／３０）、１６．７％（５／３０）和４０％（１２／３０）,而未治疗的对照组死亡５３．３％（１６／３０）。在相对增重上,治疗组分别为７３．９％、７０．１％和７１．１％,而未治疗对照组为２５．８％。